Boundless Bio (BOLD) Other Non Operating Income (2023 - 2026)
Boundless Bio (BOLD) posted quarterly Other Non Operating Income of -$2000.0 for Q1 2025, down 106.25% year-over-year from $32000.0 in Q1 2024, and up 97.65% quarter-over-quarter from -$85000.0 in Q4 2024.
Boundless Bio (BOLD) Other Non Operating Income (2023 - 2026) Analysis & Trends
Boundless Bio (BOLD) has reported Other Non Operating Income for 3 consecutive years, with -$2000.0 the latest figure, recorded in Q1 2025.
- In Q1 2025, Other Non Operating Income fell 106.25% year-over-year to -$2000.0; the TTM figure through Dec 2025 stood at -$2000.0 (down 116.67% YoY), while the FY2025 annual figure was -$2000.0, down 116.67% from the prior year.
- Other Non Operating Income grew to -$2000.0 in Q1 2025 per BOLD's latest filing, from -$85000.0 in the prior quarter.
- Across five years, Other Non Operating Income topped out at $33000.0 in Q2 2024 and bottomed at -$85000.0 in Q4 2024.
- Historically, Other Non Operating Income has averaged $6444.4 across 3 years, with a median of $32000.0 in 2023.
- On a YoY basis, Other Non Operating Income climbed as much as 218.52% in 2024 and fell as far as 365.62% in 2024.
- Boundless Bio's Other Non Operating Income stood at $32000.0 in 2023, then tumbled by 365.62% to -$85000.0 in 2024, then surged by 97.65% to -$2000.0 in 2025.
- Business Quant data shows BOLD's Other Non Operating Income at -$2000.0 in Q1 2025, -$85000.0 in Q4 2024, and $32000.0 in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Boundless Bio | 67.35 Mn | 67.35 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1,000.00 |
| Mar 31, 2025 | -2,000.00 |
| Dec 31, 2024 | -85,000.00 |
| Sep 30, 2024 | 32,000.00 |
| Jun 30, 2024 | 33,000.00 |
| Mar 31, 2024 | 32,000.00 |
| Dec 31, 2023 | 32,000.00 |
| Sep 30, 2023 | 32,000.00 |
| Jun 30, 2023 | 11,000.00 |
| Mar 31, 2023 | -27,000.00 |